(Q42089297)

16 October 2017

Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes (English)

1 reference

16 October 2017

1 reference

A Mindel

1

1 reference

16 October 2017

A Faherty

2

1 reference

16 October 2017

O Carney

3

1 reference

16 October 2017

G Patou

4

1 reference

16 October 2017

M Freris

5

1 reference

16 October 2017

P Williams

6

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 April 1988

1 reference

16 October 2017

1 reference

16 October 2017

1

1 reference

16 October 2017

8591

1 reference

16 October 2017

926-928

1 reference

A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus Infection

16 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991725-4

7 January 2021

Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991725-4

7 January 2021

Prophylactic oral acyclovir in recurrent genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991725-4

7 January 2021

INTRAVENOUS ACYCLOVIR TREATMENT FOR PRIMARY GENITAL HERPES

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991725-4

7 January 2021

A test of homogeneity for ordered alternatives

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991725-4

7 January 2021

Oral acyclovir for episodic treatment of recurrent genital herpes. Efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991725-4

7 January 2021

Double-blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2991725-4

7 January 2021

10.1016/S0140-6736(88)91725-4

Identifiers

DOI

1 reference

16 October 2017

1 reference